ICAM1 and lung cancer: Lymphocyte-EC interactions with respect to lymphocyte recruitment and homing pathways, such as ICAM1/2-integrin and HAS2/MMP7-CD44, were enriched in early stages of lung cancer nodules compared to advanced lung cancer, indicating that EC remodels lymphocytes in the direction of immunosuppression (19).